Showing results (11-20 of 131) with videos related to
Sort By:
Pageof 14
The Journal of Hospital Infection|April 3, 2002
Therapeutic options for Gram-positive infectionsM J RybakAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adultsS C Boike, B Ilson, N Zariffa, et al.Antimicrobial Agents and Chemotherapy|February 19, 2000
Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection modelE Hershberger, M J RybakThe Annals of Pharmacotherapy|October 1, 1995
Quinupristin/dalfopristin (RP 59500): a new streptogramin antibioticC Chant, M J RybakClinical Therapeutics|May 20, 1998
Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapyD E Wilson, K Kaidbey, S C Boike, et al.Antimicrobial Agents and Chemotherapy|December 1, 1995
Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clotsS L Kang, M J RybakDrugs|September 1, 1996
Combination antimicrobial therapy for bacterial infections. Guidelines for the clinicianM J Rybak, B J McGrathPharmacotherapy|June 10, 1998
The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobialsL D Dresser, M J RybakPharmacotherapy|October 8, 1999
Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin familyD R Foster, M J RybakThe Journal of Antimicrobial Chemotherapy|April 1, 1997
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clotsS M Palmer, M J RybakPageof 14